Schedule 13D ownership disclosure
Mirati Therapeutics Inc
Security class unavailable · CUSIP: 60468T105
Event date: 2017-11-16
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 9.9900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001144204-17-060212
- Form type
- SC 13D
- Filer
- BAKER BROS. ADVISORS LP
- CIK
- CIK 1263508
- Filed
- Nov 20, 2017
- Reporting period
- Nov 16, 2017
- Description
- Schedule 13D beneficial ownership